Objectives: Sepsis remains a serious clinical problem despite intensive research efforts and numerous attempts to improve outcome by modifying the inflammatory response. Substance P, the principal ligand for the neurokinin-1 receptor, is a potent proinflammatory mediator that exacerbates inflammatory responses and cardiovascular variables in sepsis. Design: The current study examined whether inhibition of the neurokinin-1 receptor with a specific antagonist 255) would improve survival in the cecal ligation and puncture model of sepsis in adult female outbred mice. Setting: University basic science research laboratory. Measurements and Main Results: Neurokinin-1 receptor treatment at the initiation of sepsis improved survival in cecal ligation and puncture sepsis (neurokinin-1 receptor antagonist survival = 79% vs vehicle = 54%). Delaying therapy for as little as 8 hours postcecal ligation and puncture failed to provide a survival benefit. Neurokinin-1 receptor antagonist treatment did not prevent the sepsis-induced decrease in circulating WBCs, augment the early (6 hr postcecal ligation and puncture) recruitment of inflammatory cells to the peritoneum, or improve phagocytic cell killing of pathogens. However, the neurokinin-1 receptor antagonist significantly reduced both circulating and peritoneal cytokine concentrations.
D
espite the significant research investments made to understand the pathophysiology of sepsis, in hopes of discovering targeted pharmacologic therapies, no single therapy has proved to be effective (1, 2) . Therapeutic approaches such as attenuating acute inflammation by cytokine inhibition (i.e., interleukin [IL]-1, tumor necrosis factor-α), globally suppressing inflammation with steroid administration, or altering the innate immune system with toll 4 antagonists have been futile (1, 3, 4) . Managing the 750,000 patients of sepsis each year remains a significant burden to our healthcare system (5) . With a mortality rate of 30%, sepsis accounts for a significant number of deaths in noncoronary ICUs (6) , although recent data have shown that sepsis mortality has stabilized (7) . The consensus definitions for sepsis were revised in 2016 to emphasize that sepsis represents a dysregulated host response to infection (8) .
Substance P (SP), a proinflammatory neuropeptide belonging to the tachykinin family, plays an integral role in the inflammatory cascades affecting the vascular response in acute inflammation. This vascular response has been referred to as "neurogenic inflammation." After a noxious stimulus, such as a septic insult, SP is released by sensory neurons and inflammatory cells and binds to the neurokinin-1 receptor (NK-1R), which can be found throughout the CNS, peripheral tissues, endothelial cells, and other inflammatory cells. This leads to activation of the signal transduction pathway ERK 1/2 followed by upregulation of nuclear factor κB and clinical sequelae as exhibited by the systemic inflammatory response with multiple organ dysfunction (9) .
It was recently shown that SP release exerts a significant inflammatory response in a polymicrobial model of animal sepsis. Using cecal ligation and puncture (CLP) in mice, a welldescribed model of sepsis in animals (10) , investigators showed that plasma and lung SP concentrations peak within 1 hour after an infectious challenge (11) . Furthermore, the inflammatory response within the lungs, defined by proinflammatory cytokine release and increased myeloperoxidase levels, was attenuated when the NK-1R was blocked (12) . Similar findings were reproduced in a CLP model using genetically modified mice that lack the ability to produce SP (11) .
Previous literature suggests that the NK-1R may be a potential target for therapeutic modulation, given its key role in the pathogenesis of sepsis. However, no clear mechanism has been elucidated to explain its therapeutic benefit. Blocking SP binding to the NK-1R may improve sepsis survival by decreasing cytokine production, increasing inflammatory cell recruitment to the site of infection, or improving cardiac output. In this study, we characterized the mechanisms by which inhibiting the SP-NK-1R axis improves survival using the CLP-induced sepsis model. We tested the hypothesis that NK-1R blockade would modulate the local and systemic inflammatory responses and attenuate the cardiovascular dysfunction frequently observed in sepsis.
METHODS Animals
Female, Institute of Cancer Research (ICR) mice 8-10 weeks old were acclimated to the laboratory for 2 weeks in a humidity and temperature controlled housing with a 12-hour light:dark diurnal cycle before any intervention. Food and water was provided ad libitum for the entire duration of the study period. All studies were approved by the Institutional Animal Care and Use Committee at Boston University School of Medicine and performed following National Institutes of Health guidelines.
CLP Model
Polymicrobial peritonitis was induced by subjecting mice to CLP as first published (13) with minor modifications (14, 15) . Briefly, general anesthesia was induced with 5% isoflurane, with 3% for maintenance. The abdominal wall was prepped with chloraprep antibacterial solution (BiMeda, Le Sueur, MN) followed by a 1-cm incision through the abdominal wall. Ligation of 75% of the cecal length and double puncture with a 16-gauge needle was performed. Before abdominal wall closure, a NK-1R antagonist (NK-1RA), CJ-12,255, 25 mg/kg (Pfizer, Groton, CT) prepared in 0.5 mL of 0.9% saline was administered intraperitoneally (IP); control mice received the vehicle. The dose was selected on the basis of the literature (16) . Prior publications in experimental animals show that NK-1RAs in normal animals do not alter heart rate or other baseline measurements (data not shown) (17, 18) , so this control group was not studied. CJ-12,255 was administered IP for a total of six doses every 12 hours. Mice were resuscitated with 1 mL of 37°C normal saline with buprenorphine (0.5 mg/ kg) injected subcutaneously (SC). Postoperative analgesia was maintained with buprenorphine 0.5 mg/kg administered every 12 hours SC for 48 hours. Antibiotic treatment with imipenem 25 mg/kg (Merck, West Point, PA) was started 2 hours after surgery and administered SC every 12 hours for six doses.
To assess the therapeutic efficacy of the NK-1RA, a delayed treatment protocol was performed. A group of ICR mice underwent CLP after which they were risk stratified on the basis of their 6-hour post-CLP plasma IL-6 levels to predict which mice would succumb to death (predicted to die [Die-P]) in the first 5 days post-CLP and which would survive (predicted to live [Live-P]). Using receiver operator characteristic curves, an IL-6 cutoff of 16 ng/ mL was used to predict survival, as described previously (19) (20) (21) . Administration of CJ-12,255 was delayed by 8 hours after CLP and administered to risk-stratified mice as described below (22) .
Blood and Peritoneal Fluid Collection
Blood was collected by facial vein puncture in 20 μL quantities at various time points as described previously (23, 24) . Blood was collected before CLP and at 6, 24, 48, 72, and 120 hours. The blood was immediately diluted in 180 μL of phosphate buffered saline (PBS) -ethylenediaminetetraacetic acid (EDTA) (3.3 mM) and used for evaluation of cytokines and complete blood count with differential with a Hemavet instrument (CDC Technologies, Oxford, CT). In a separate experiment, groups of ICR mice were killed at either 6 or 24 hours post-CLP using a cocktail of ketamine 87 μg/gm and xylazine 13 μg/gm mixed in normal saline. Using sterile technique, the peritoneal cavity was lavaged with 1 mL of warm Hanks balanced salt solution containing 50 mM EDTA, which was used for microbiology cultures and peritoneal cytokine analysis. Another 24 mL of fluid was used to lavage the peritoneal cavity. After collection, the fluid was combined with the first milliliter and filtered through a 70-m nylon filter (BD Biosciences, San Jose, CA) to remove peritoneal debris. The peritoneal fluid was centrifuged at 450 × g for 5 minutes to isolate the cell pellet used to count total cells using a Beckman-Coulter particle counter model ZF (Coulter Electronics, Hialeah, FL). Cytospin slides were prepared from the harvested cells and stained with Diff-quick (Dade Behring, Newark, DE).
Systems, Minneapolis, MN). An aliquot of plasma or peritoneal fluid was used to determine IL-6, macrophage inflammatory protein 2 (MIP-2), and IL-1 receptor antagonist (IL-1RA) by ELISA as previously described (25) .
Opsonization/Phagocytosis Assay
Phagocytosis by peritoneal cells after sepsis was measured as previously published (26) . Briefly, peritoneal cells (4 million/ mL) were incubated with opsonized pHrodo Escherichia coli bioparticles (Life Technologies, Carlsbad, CA) at a ratio of 20 bioparticles-to-cell. Incubations were performed at 37°C or on ice (negative control). Cells were then stained with GR-1 (neutrophils) and CD11b (macrophages; BD biosciences, Franklin Lakes, NJ). Flow cytometric (FACS) analysis was used to determine phagocytic activity of neutrophils and macrophages.
Evaluation of Cardiovascular Variables
Cardiovascular variables were measured using the Mouse Ox collar sensor and software (Starr Life Sciences, Oakmont, PA) as described (27) . To minimize the external stress, the noninvasive cervical collar was applied for 5 minutes before obtaining heart rate and pulse distension values. The measured variables included heart rate and pulse distension, a surrogate for stroke volume.
Leakage of Plasma Proteins Into Intestines
Leakage of plasma proteins into the intestines has been previously described after CLP (28). Evans's blue will bind to albumin and may be used to measure leakage of albumin into the lumen of the intestine and measured by near-infrared spectroscopy. For these experiments, animals were injected with 0.2% bodyweight of a 1% (w/v) Evans' Blue solution in PBS by tail vein injection 2 hours before sacrifice. Mice were killed as above to collect blood from the retroorbial venous plexus into 100 µL of heparin. A 3-mm section of intestine in the most edematous area was removed, opened, and placed lumen side down for scanning on an Odyssey near-infrared scanner (LiCor, Lincoln, NE). Image settings were Intensity 2.0, Focus offset 1.5 mm, quality high, resolution 42 µm. Background was subtracted, and integrated intensity of the section was obtained. One hundred microliters of plasma was analyzed in a 96-well plate using settings: intensity 5.0, focus offset 3.0 mm, quality high, resolution 84 µm with background subtraction. Integrated intensity of the well was obtained and used to calculate the ratio of blood-to-intestine so that a higher value indicates less extravasation of albumin.
Statistical Analysis
Statistical analysis was performed using Prism 5 (GraphPad Software, San Diego, CA). For survival analysis, a KaplanMeier curve and log rank survival were performed. All values were expressed in mean ± se. Student t test was used to compare data between two groups. For repeated measures data, such as the cardiovascular variables, the data were analyzed using repeated measures analysis of variance with Bonferroni correction. The area under the curve (AUC) for the temporal cytokine response was calculated for each mouse individually and then summed. Because cytokines are not detectable before CLP, time 0 values were assigned a value equal to one half the lower limit of detection of the assay.
RESULTS

Early Blockade of NK-1R Improves Sepsis Survival in Outbred Mice
The first experiment evaluated whether an NK-1RA would improve survival in the murine CLP model of sepsis. For these studies, the NK-1RA was given immediately after CLP because prior work demonstrated that SP is released within the first hour post-CLP and returns to baseline levels within 16 hours (11). Survival was significantly higher in mice treated with NK-1RA. Mice that received the vehicle had a 50% survival, which improved to nearly 80% when mice were treated with NK-1RA (Fig 1) .
Our hypothesis is that SP released during the first hours of the septic response modulates immune and cardiovascular function to improve survival. This hypothesis was tested by delaying treatment. Previously, we and others published that plasma levels of IL-6 obtained 6 hours post-CLP accurately predict mortality (19, 21, 22) . For the current study, all mice underwent CLP and plasma was collected 6 hours post-CLP. The IL-6 concentrations were then used to stratify mice into those Live-P or Die-P. NK-1RA treatment was started 8 hours post-CLP, creating four groups of mice, listed in Table 1 . Delaying administration of NK-1RA failed to improve pulse distension, reduce IL-6, or improve survival in any of the groups. (Table 1) .
Pharmacologic Blockade of NK-1R Reduces Plasma Cytokines in Sepsis
The septic response in CLP mice includes significant production of proinflammatory cytokines as well as cytokine inhibitors (22, 29) . These outbred ICR mice were subjected to our standard CLP model and treated with the NK-1RA immediately after CLP. Intraperitoneal administration of NK-1RA every 12 hours was continued during the first 3 days of sepsis. Serial collection of plasma from the facial vein allowed for evaluation of the temporal pattern of systemic inflammatory response assessed by the plasma levels of IL-6 (Fig 2A), MIP-2 (Fig 2B) , and IL-1RA (Fig 2C) . Mice treated with the NK-1RA at the time of CLP had significantly lower concentrations after CLP (Fig. 2) . The total cytokine response through the first 48 hours was determined by calculating the AUC for individual mice to allow Critical Care Medicine www.ccmjournal.org e217 a better analysis of the cytokine and cytokine inhibitor response during this early phase. For IL-6, MIP-2, and IL-1RA, the AUC was significantly less for the NK-1RA-treated mice compared with normal saline mice (Fig 2D) . These data demonstrate that treatment with NK-1RA decreased both proinflammatory cytokines (IL-6 and MIP-2) as well as suppressing the cytokine inhibitor IL-1RA.
NK-1RA Does not Prevent Early Decreases in WBC
Peritoneal sepsis induces a transient reduction in the WBC count, which rebounds after 3-5 days (15) . During the first 3 days of the septic response, the decrease in WBC still occurred despite the blockade of the NK-1R. Figure 3 demonstrates that the baseline WBC was 5 × 10 6 cells in the blood. As described by Hotchkiss et al (30) , the WBC drops dramatically shortly after septic challenge as a result of lymphocyte apoptosis, a trend observed in both the NK-1RA-treated mice and mice that received the vehicle. By the last day of the acute phase of sepsis (day 5 [15] ), it became evident that mice treated with NK-1RA had significantly lower WBC counts compared with the vehicle controls (Fig. 3A) . This holds true among all peripheral blood cell populations including neutrophils (Fig 3B), lymphocytes (Fig. 3C) , and monocytes ( Fig 3D) . As the cellular response in acute inflammation recovered, the WBC rebounded above baseline in vehicle-treated mice whereas in the NK-1RA-treated mice the WBC count levels only recovered to baseline.
NK-1RA Decreases Peritoneal IL-6 and MIP-2
Because administration of NK-1RA decreased plasma cytokine concentrations, the local inflammatory effects compartmentalized within the peritoneum were examined. Peritoneal lavage was performed in mice killed either 6 or 24 hours after CLP. Those killed at 6 hours received just one dose of NK-1RA whereas those killed at 24 hours received three doses. Paralleling the systemic inflammatory response, the concentrations of IL-6 and MIP-2 in the peritoneal fluid at 6 hours were significantly lower in mice that received the NK-1RA as compared with the saline controls (Fig. 4, A and B) . Mice treated with the NK-1RA had equivalent concentrations of IL-6 and MIP-2 at 24 hours. No difference was apparent in the anti-inflammatory IL-1RA concentration within the peritoneum at either of the early time points (Fig. 4C) .
NK-1RA Does not Decrease 6-Hour Peritoneal Cell Recruitment
The local cytokine release within the peritoneum has been shown to play a pivotal role in the recruitment of inflammatory cells that play an important role in the eradication of the enteric pathogens associated with cecal injury (24, 31) . Because the NK-1RA reduced MIP-2 production within the peritoneal cavity (Fig 4B) , we studied whether polymorphonuclear leukocyte recruitment would be impaired. Although there were essentially no neutrophils found in the sterile abdomen, millions of these inflammatory cells are rapidly recruited to the infected peritoneum within hours after CLP. NK-1RA treatment did not reduce the number of inflammatory cells recruited to the peritoneum at 6 hours. However, a substantial difference in the inflammatory cell count was apparent by 24 hours after CLP; mice treated with NK-1RA had significantly fewer peritoneal cells compared with mice treated with the vehicle (Fig. 5A) .
In addition, the number of peritoneal inflammatory cells decreased between 6 and 24 hours in NK-1RA-treated mice, whereas the mice given the vehicle had an increase in the number of peritoneal cells. The recruitment of inflammatory cells within 6 hours of CLP has been shown to be important in the control of sepsis (24), and NK-1R treatment did not alter this early response. 
NK-1RA Does not Decrease Bacterial Growth or Improve Phagocytic Cell Function
To determine whether there would be any difference in the growth of peritoneal bacteria, serial dilutions of the peritoneal lavage were cultured on blood agar plates in both aerobic and anaerobic conditions. There were no significant differences in the number of bacteria within the peritoneal cavity at 6 or 24 hours post-CLP (Fig 5B) . Because there were similar numbers of peritoneal bacteria, it also indicates that the administration of CJ-12,255 into the peritoneal cavity did not alter bacterial replication. As there were fewer inflammatory cells at 24 hours post-CLP, but equivalent numbers of bacteria, we evaluated whether cells in NK-1R treated mice functioned more efficiently within the peritoneum. In other words, fewer peritoneal neutrophils at 24 hours post-CLP ( Fig 5A) were still able to control the local infection (Fig 5B) . To evaluate phagocytic function more closely, peritoneal neutrophils and macrophages were harvested from both treated and control mice 24 hours after CLP. These cells were then incubated with exogenous E. coli labeled with a pH-sensitive probe in an assay that determines whether the bacteria have been incorporated into phagolysosomes (26, 32) . Specific cell surface markers were used to distinguish phagocytic activity of neutrophils versus macrophages. Antagonism of the NK-1R did not alter the phagocytic capacity of either neutrophils (Fig 5C) or macrophages (Fig 5D) .
NK-1R Blockade Improves Early Cardiac Output
Monitoring physiologic variables and vital signs may provide insight into the cardiovascular responses during the septic challenge, critical components in sepsis management. To better characterize the hemodynamic changes, vital signs were measured serially using a noninvasive cervical collar probe. The probe senses local blood flow at the level of the carotid artery to measure pulse distension (a stroke volume surrogate) and heart rate. Treatment with the NK-1RA decreased the early decline in pulse distension after CLP (Fig 6A) . To highlight the early improvement in pulse distension, the values at 1 and 6 hours post-CLP were graphed separately (Fig 6B) . At these early time points, antagonism of NK-1R reduced the decline in pulse distension compared with vehicle. Other cardiovascular variables were also studied because the CNS helps regulate heart rate. Neurons within the paraventricular nucleus express NK-1R, which modulate stressinduced changes in heart rate (33) . In our studies, treatment with the NK-1RA did not alter the heart rate (Fig 6C) . This finding is likely due to the fact that the NK-1RA used in these studies does not cross the blood-brain barrier and thus does not affect the paraventricular nucleus responsible for regulating heart rate.
Vascular leak into the intestines has been demonstrated after CLP (28) . Decreased early cardiac output at 1 and 6 hours ( Fig  6B) should exacerbate the damage to the intestine and increase vascular leak. This was measured by injecting Evans' blue dye IV 22 hours after CLP and killing mice 2 hours later. Figure 7 shows that mice subjected to CLP had significant leakage into the intestine compared with naive mice. Treatment with the NK-1RA significantly reduced the vascular leak to levels similar to naive animals.
DISCUSSION
The current study takes advantage of recent evidence demonstrating that SP peaks early in acute inflammation after CLP (9, 11) . We have demonstrated that modulating the Critical Care Medicine www.ccmjournal.org e219 inflammatory effects of SP with a receptor antagonist in the initial septic response improves survival in the murine CLP sepsis model. Blocking the NK-1R exerts an anti-inflammatory effect coupled with improved cardiovascular function during the first 6 hours of murine peritonitis. However, the cytokine reduction, especially within the peritoneum, was relatively mild. In addition, there was no significant change in circulating WBCs, 6-hour peritoneal cell recruitment, or phagocytic cell function with NK-1R blockade. Although there was a significant reduction in both the systemic and local cytokine response after the inhibition of NK-1R, this reduced cytokine response does not explain why mice exhibited improved survival in severe sepsis. Better survival with NK-1R antagonism probably occurs through multiple mechanisms. Cardiovascular responses during sepsis are important determinants of survival. Cardiovascular depression-defined by reduced mean arterial pressure, stroke volume, and cardiac output-has been demonstrated in experimental preclinical models of sepsis including pneumonia and CLP. Interestingly, the stroke volume curves obtained by Zanotti-Cavazzoni et al (34) assessing fluid resuscitation are nearly identical to the pulse distension curves obtained in our study. Although the end result in both studies demonstrated improved survival secondary to improved cardiovascular performance, the mechanisms are different. Whereas the former study adopted the goal directed resuscitation philosophy to improve survival in severe sepsis in the murine model of CLP, we pharmacologically attenuated the NK-1R interaction. A 2016 study defined that physiologic deterioration after CLP occurred within 8 hours (35), results nearly identical to our data. This early deterioration also reinforces why delayed treatment with the NK-1RA at 8 hours was not effective.
Prior publications using SP knockout (SP-KO) mice to evaluate the role of SP in the mortality of CLP-induced sepsis (11) showed that the SP-KO mice had better survival after CLP, consistent with our current findings. Despite these similarities, there are important differences between the studies. In the study by Puneet et al (11) , there was 100% mortality within 24 hours in the wild-type mice, and the SP-KO mice still had 100% mortality by 5 days. In contrast, our study had 50% mortality by 7 days in the vehicle-treated mice, which was improved to 80% with the NK-1R blockade. The role of NK-1R in the clearance of bacteria was studied using a model of staphylococcal sepsis. Verdrengh and Tarkowski (36) showed that NK-1R knockout mice had increased bacteria in the kidneys and decreased survival, which differ from our results. These differences may relate to different pathogens and complete loss of SP signaling throughout the host rather than the NK-1RA treatment used in the current study. The concept that NK-1R antagonism given at the onset of sepsis reduces the signaling pathways, that is, NF-κB, that results in cytokine production has also been reported (37) .
Using a different model of infection, we have previously published that early blockade of the SP receptor decreases survival (38) , results different than the current findings. There are several explanations for these discordant results. In the prior publication, mice were subjected to mild traumatic brain injury (mTBI) and 2 days later Gram-negative pneumonia was induced with Pseudomonas aeruginosa, so there are substantial differences in the models. Although both pneumonia and peritonitis cause sepsis, the disease processes are very different. In the mTBI model, NK-1R was blocked for 2 days before the start of the infection, . At 24 hr, the mice treated with NK-1RA not only had decreased cell counts compared with the vehicle (n = 16 for both groups) but also had lower values than treated mice at 6 hr. B, NK-1RA treatment did not affect bacterial burden colony forming units (CFUs) at either time point suggesting that infectious burden was similar between the two groups (n = 16 for both groups). Hypothesizing that these findings were attributed to improved cell efficiency at killing bacterial burden, an ex vivo phagocytosis assay of isolated C, polymorphonuclear leukocyte (PMN) (n = 5 per group) and D, macrophages (MAC) (n = 5 per group) was performed. There was no difference in phagocytic cell function with NK-1RA treatment. *p < 0.05 vehicle compared with NK-1RA.
whereas in the current article, the blockade began when the infection began. Finally, in the mTBI model, there was nearly 100% lethality among the control mice whereas the current study had approximately 50% lethality. Prior work has demonstrated that the effectiveness of therapy depends on the mortality, that is, therapies effective in high-mortality models are not effective in lower-mortality models (22) . Neuropeptides have not been widely studied in clinical sepsis despite their potent immunoregulatory and vasoactive properties. Furthermore, the little data that have been published is controversial. Although one study suggests that SP is not elevated in sepsis (39) , another one concludes SP levels are elevated and, more importantly, SP levels correlate with mortality (40) . This controversy has probably been resolved by the recent publication of a larger clinical study showing that serum levels of SP correlate with survival (41). Our current study demonstrates that the SP blockade is probably not an appropriate therapeutic target because it made so quickly in the septic response such that there would not be sufficient time to intervene. However, the neuropeptide SP does play a significant role in the mortality of sepsis.
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A B Figure 6 . Cardiovascular variables improved with neurokinin-1 receptor (NK-1R) antagonism. Using a noninvasive infrared cervical probe, cardiovascular variables including pulse distension (a surrogate for stroke volume) and heart rate were obtained after cecal ligation and puncture (CLP). A, In the NK-1R antagonist (NK-1RA) treated mice, the sepsis-induced decrease in pulse distension was less than the decrease observed in vehicle-treated mice (NK-1RA, n = 15, vehicle n = 12). B, To highlight the early changes, the pulse distension at 1 and 6 hr post-CLP is displayed, which shows that the NK-1RA mice maintained their pulse distension better than the mice only given vehicle. C, NK-1RA mice had essentially the same changes in heart rates throughout the first 48 hr of sepsis (NK-1RA n = 12, vehicle n = 15). *p < 0.05 between the two groups. 
